Targeting human TLRs to combat COVID‐19: A solution?

Development of epitope‐based peptide vaccine against novel coronavirus 2019 (SARS‐COV‐2): Immunoinformatics approach

(2020) Manojit Bhattacharya et al.   JOURNAL OF MEDICAL VIROLOGY

COVID-19: towards understanding of pathogenesis

(2020) Wei Cao et al.   CELL RESEARCH

SARS-CoV-2 and viral sepsis: observations and hypotheses

(2020) Hui Li et al.   LANCET

Clinical and biological data on the use of hydroxychloroquine against SARS‐CoV‐2 could support the role of the NLRP3 inflammasome in the pathogenesis of respiratory disease

(2020) Alessandro Lucchesi et al.   JOURNAL OF MEDICAL VIROLOGY

Design of a peptide-based subunit vaccine against novel coronavirus SARS-CoV-2

(2020) Parismita Kalita et al.   MICROBIAL PATHOGENESIS

Toll‐like receptor polymorphism in host immune response to infectious diseases: A review

(2019) Suprabhat Mukherjee et al.   SCANDINAVIAN JOURNAL OF IMMUNOLOGY

Toll-like receptors: promising therapeutic targets for inflammatory diseases

(2016) Asma Achek et al.   ARCHIVES OF PHARMACAL RESEARCH

TLR2 and TLR4 mediated host immune responses in major infectious diseases: a review

(2016) Suprabhat Mukherjee et al.   Brazilian Journal of Infectious Diseases